Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10
Clinical trial NCT03294707 · COMPLETED
Trial details
- NCT number
- NCT03294707
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-11
- Primary completion
- 2018-02-05
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.